Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-18

Clinical Trial Update: Recurrent AA Amyloidosis After Renal Transplantation

View source ↗

Summary

This entry reports the completion of a clinical trial evaluating recurrent AA amyloidosis after renal transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Istanbul University | Conditions: AA Amyloidosis | Status: COMPLETED